Potansiyel Malign Bozukluklar Ve Ağız Kanseri Şüphesi Bulunan Lezyonlara Yaklaşım Ve Diş Hekimlerinin Erken Tanıdaki Rolü

Dünya Sağlık Örgütü’nün DSÖ 1998 yılı raporuna göre ağız kanserleri insandaki öldürücü sekiz kanser tipinden bir tanesidir. Ağız kanserinin öldürücü olmasının nedeni çok defa geç dönemde, bölgesel lenf metastazlarıyla birlikte saptanması ve ayrıca geniş cerrahi müdahalelere rağmen nükslerin engellenememesidir. Ağız kanserleri normal mukozada gelişebileceği gibi potansiyel malign bozukluklar olarak sınıflanan bir grup lezyon ve durum zemininde de gelişebilmektedir. Tüm bu lezyonlar ve erken dönem ağız kanseri diş hekimlerinin, pratisyen hekimlerin, kulak-burun boğaz uzmanlarının ve hatta hastanın kendisinin bile kolaylıkla ulaşabileceği, göz önünde bir bölgede gelişirler ve dolayısıyla erken teşhis edilme şansı taşırlar. Bu derlemede en sık izlenen potansiyel malign bozukluklar olan lökoplaki, eritroplaki ve ağız kanserlerine yaklaşım, erken tanı yöntemleri ve diş hekimlerinin bu konudaki sorumluluğuna dikkat çekilmektedir

Approach To Potentially Malignant Disorders And Suspicious Lesions For Oral Cancer And The Role Of Dentists In Early Diagnosis

According to World Health Organisation’s 1998 report, oral cancer has a very high risk of mortality rate. The reason of high mortality rate of oral cancer is diagnosis at late stage of the disease generally with regional lymph node metastasis and high risk of recurrence despite large surgical treatment. Oral cancer may appear either on normal oral mucosa or from a potentially malignant disorder. Since, all these lesions and early invasive oral cancer is easily visible for dentists, physicians, ear-nosethroat specialist, and even the patient himself, they have the chance to be diagnosed at early stage.This review aimed to highlight the approaches to leukoplakia, erythroplakia and oral cancer as well as modilities in early diagnosis, and responsibility of dentist on this subject

___

  • Mehrotra R., Mishra S., Singh M. The efficacy of oral brush biopsy with computer-assisted analysis in iden- tifying precancerous and cancerous lesions. Head Neck Oncol. 3:39, 2011.
  • Seoane J., Corral-Lizana C., Gonzalez-Mosquera A., Cerero R., Esparza G., Sanz-Cuesta T. The use of cli- nical guidelines for referral of patients with lesions sus- picious for oral cancer may ease early diagnosis and improve education of healthcare professionals. Med. Oral Patol. Oral Cir. Bucal. 16:e864-869, 2011.
  • Johnson NW., Jayasekara P., Amarasinghe AA. Squ- amous cell carcinoma and precursor lesions of the oral cavity: epidemiology and aetiology. Periodontol 2000 57:19-37, 2011.
  • Groome PA., Rohland SL., Hall SF., Irish J., Mackillop WJ., O’Sullivan B. A population-based study of factors associated with early versus late stage oral cavity can- cer diagnoses. Oral Oncol. 47:642-647, 2011.
  • Amagasa T. Oral premalignant lesions. Int. J. Clin. Oncol. 16:1-4, 2011.
  • Goodson ML., Thomson PJ.. Management of oral car- cinoma: benefits of early precancerous intervention. Br. J. Oral Maxillofac. Surg. 49:88-91, 2011.
  • Oygür T. Ağız kanserleri konusunda toplumdaki far- kındalık düzeyi. ADO Klinik Bilimler Dergisi 3(3):424- 432, 2009.
  • Poh CF., Williams PM., Zhang L., Rosin MP. Heads up - a call for dentists to screen for oral cancer. J. Can. Dent. Assoc. 72:413-416, 2006.
  • Pentenero M., Navone R., Motta F., Marino R., Gas- sino L., Broccoletti R. Clinical features of microinvasive stage I oral carcinoma. Oral Dis. 17:298-303, 2011.
  • Amagasa T., Yamashiro M., Uzawa N. Oral prema- lignant lesions: from a clinical perspective. Int. J. Clin. Oncol. 16:5-14, 2011.
  • Kramer IR., Lucas RB., Pindborg JJ., Sobin LH. Defi- nition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg. Oral Med. Oral Pathol. 46:518-539, 1978.
  • van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classi- fication and present concepts of management. Oral Oncol. 45:317-323, 2009.
  • Warnakulasuriya S., Johnson NW., van der Waal I. Nomenclature and classification of potentially ma- lignant disorders of the oral mucosa. J. Oral Pathol. Med. 36:575-580, 2007.
  • Izumo T. Oral premalignant lesions: from the patholo- gical viewpoint. Int. J. Clin. Oncol. 16:15-26, 2011.
  • Warnakulasuriya S. Squamous cell carcinoma and precursor lesions: prevention. Periodontol 2000 57:38-50, 2011.
  • Villa A., Villa C., Abati S. Oral cancer and oral ery- throplakia: an update and implication for clinicians. Aust. Dent. J. 56:253-256, 2011.
  • van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; present concepts of management. Oral Oncol. 46:423-425, 2010.
  • Woolgar JA., Triantafyllou A. Squamous cell carcino- ma and precursor lesions: clinical pathology. Perio- dontol 2000 57:51-72, 2011.
  • Regezi JA., Scuibba JJ., Jordan RCK. Oral Pathology Clinical Pathologic Correlations. Elsevier Inc.; 2008.
  • Hashibe M., Mathew B., Kuruvilla B., Thomas G., Sankaranarayanan R., Parkin DM. Chewing tobac- co, alcohol, and the risk of erythroplakia. Cancer Epi- demiol Biomarkers Prev. 9:639-645, 2000.
  • Reichart PA., Philipsen HP. Oral erythroplakia--a revi- ew. Oral Oncol. 41:551-561, 2005.
  • Scheer M., Neugebauer J., Derman A., Fuss J., Drebber U., Zoeller JE. Autofluorescence imaging of potentially malignant mucosa lesions. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 111:568-577, 2011.
  • Mendes SF., de Oliveira Ramos G., Rivero ER., Modolo F., Grando LJ., Meurer MI. Techniques for precancerous lesion diagnosis. J. Oncol. 2011:326094, 2011
  • Cancela-Rodriguez P., Cerero-Lapiedra R., Esparza- Gomez G., Llamas-Martinez S., Warnakulasuriya S. The use of toluidine blue in the detection of pre-malig- nant and malignant oral lesions. J. Oral Pathol. Med 40:300-304, 2011.
  • Mehrotra R., Gupta DK. Exciting new advances in oral cancer diagnosis: avenues to early detection. Head Neck Oncol. 3:33, 2011.